期刊文献+

氟喹诺酮药物浓度对金黄色葡萄球菌耐药突变株选择的影响 被引量:10

Effect of fluoroquinolone concentration on the selection of resistant mutants of Staphylococcus aureus
在线阅读 下载PDF
导出
摘要 目的了解氟喹诺酮药物浓度对金葡菌耐药突变株选择的影响。方法将金葡菌ATCC 25923接种于不同浓度环丙沙星及加替沙星琼脂平皿上,根据不同药物浓度平皿上生长的菌落数.计算菌落生长比例。对不同药物浓度筛选出的耐药突变株进行编码拓扑异构酶ⅣC亚单位基因par C(grl A)和促旋酶A亚单位基因gyr A喹诺酮耐药决定区的PCR扩增和测序,并测定外排泵抑制剂利血平对环丙沙星和加替沙星MIC的影响。结果药物浓度对平皿中生长的菌落数有明显影响。环丙沙星在低、中浓度主要选择出主动外排泵介导的非靶位耐药突变株,高浓度选择出Grl A变异的耐药突变株,以Ser-80→Phe为主。加替沙星低浓度选择出非靶位及靶位变异菌株,而中、高浓度均选择出Grl A变异株,也以Ser-80→Phe为主。结论氟喹诺酮药物浓度对金葡菌耐药突变株菌落数以及耐药位点的选择都有明显影响。 Objective To study the effect of fluoroquinolone concentration on the selection of resistant mutants of S. aureus. Methods The S. aureus strain ATCC 25923 was enriched in broth and the cells were plated on Mueller-Hinton agar plates containing ciprofloxacin or gatifloxacin. Colonies on each plate were counted and the recovery of input cells was calculated. Quinolone resistance-determining region (QRDR) mutations of parC (grlA) and gyrA of resistant mutants were identified by PCR amplification and gene sequencing. The effect of efflux-pump inhibitor reserpine on MICs of gatifloxacin and ciprofloxacin for resistant mutants was determined by agar dilution method. Results Fluoroquinolone concentration had strong influence on the recovery of resistant colonies and the selection of resistant allele. The colonies selected at low and medium concentration of ciprofloxacin were largely non-target mutants,and at high concentration, Ser-80→Phe GrlA mutants dominated. Non-target and GrlA mutants were selected by gatifloxacin at low concentration, and Ser-80→Phe GrlA mutants were selected mainly at medium and high concentration. Conclusions Fluoroquinolone concentration has strong influence on the recovery of resistant colonies and the resistant allele selection. In clinical practice, the selection of resistant mutants could be prevented by choosing higher drug doses that one can tolerate.
出处 《中国感染与化疗杂志》 CAS 2006年第5期309-312,共4页 Chinese Journal of Infection and Chemotherapy
基金 国家自然科学基金资助项目(30370615)。
关键词 氟喹诺酮 金黄色葡萄球菌 耐药 防耐药变异浓度 Fluoroquinolones Staphylococcus aureus Drug resistance Mutant prevention concentration
  • 相关文献

参考文献9

  • 1Zhou J,Dong Y,Zhao X,et al.Selection of antibiotic-resistant bacterial mutants:allelic diversity among fluoroquinolone-resistant mutations[J].J Infect Dis,2002,182:517-525.
  • 2Dong Y,Zhao X,Domagala J,et al.Effect of fluoroquinolone concentration on selection of resistant mutants of Mycobacterium bovis BCG and staphylococcus aureus[J].Antimicrob Agents Chemother,1999,43:1756-1758.
  • 3Zhao X,Eisner W,Perl-Rosenthal N,et al.Mutant prevention concentration of garenoxacin (BMS-284756) for ciprofloxacin-susceptible or -resistant Staphylococcus aureus[J].Antimicrob Agents Chemother,2003,47:1023-1027.
  • 4许飞,段德卿,林耀广.金黄色葡萄球菌对喹诺酮耐药的主动外排机制的研究[J].中华结核和呼吸杂志,2004,27(6):403-406. 被引量:8
  • 5李家泰,李耘,王进,中国细菌耐药监测研究组.中国医院和社区获得性感染革兰阳性球菌耐药性监测研究[J].中华医学杂志,2003,83(5):365-374. 被引量:198
  • 6Zhao X,Drlica K.Restricting the selection of antibiotic-resistant mutants:a general strategy derived from fluoroquinolones studies[J].Clin Infect Dis,2001,33(Suppl 3):S147-S156.
  • 7Drlica K.The mutant selection window and antimicrobial resistance[J].J Antimicrob Chemother,2003,52:11-17.
  • 8崔俊昌,刘又宁,王睿,梁蓓蓓,裴斐,郑专杰.4种氟喹诺酮类药物对金黄色葡萄球菌的防耐药变异浓度[J].中华医学杂志,2004,84(22):1863-1866. 被引量:34
  • 9Li X,Mariano N,Rahal JJ,et al.Quinolone-resistant Haemophilus influenzae:determination of mutant selection window for ciprofloxacin,garenoxacin,levofloxacin,and moxifloxacin[J].Antimicrob Agents Chemother,2004,48:4460-4462.

二级参考文献14

  • 1李家泰,张烨,陈亦芳,郝凤兰,陈扬.E test for studying in vitro activity of seven antimicrobial agents against penicillin-susceptible and penicillin-resistant pneumococci[J].Chinese Medical Journal,2000(7):52-55. 被引量:3
  • 2Shalit I, Berger SA, Gorea A, et al. Widespread quinolone resistance among methicillin-resistant Staphylococcus aureus isolates in a general hospital. Antimicrob Agents Chemother, 1989,33:593-594.
  • 3Nikaido H.Prevention of drug access to bacterial targets:permeability barriers and active efflux. Science, 1994,264:382-388.
  • 4Neyfakh AA, Borsch CM, Kaatz AW. Fluoroquinolone resistance protein NorA of Staphylococcus aureus is a multidrug efflux transporter. Antimicrob Agents Chemother, 1993,37:128-129.
  • 5Markham PN, Neyfakh AA. Inhibition of the multidrug transporter NorA prevents emergence of norfloxacin resistance in Staphylococcus aureus. Antimicrob Agents Chemother, 1996,40:2673-2674.
  • 6Markham PN. Inhibition of the emergence of ciprofloxacin resistance in Streptococcus pneumoniae by the multidrug efflux inhibitor reserpine.Antimicrob Agents Chemother, 1999,43:988-989.
  • 7Ahmed M, Borsch CM, Neyfakh AA,et al. Mutants of the Bacillus subtilis multidrug transporter Bmr with altered sensitivity to the antihypertensive alkaloid reserpine. J Biol Chem,1993,268:11086-11089.
  • 8Brenwald NP, Gill MJ, Wise R. Prevalence of putative efflux mechanism among fluoroquinolone-resistant clinical isolates of Streptococcus pneumoniae. Antimicrob Agents Chemother,1998,42:2032-2035.
  • 9Ferrero L,Cameron B, Manse B,et al. Cloning and primary structure of Staphylococcus aureus DNA topoisomerase Ⅳ:a primary target of fluoroquinolones. Mol Microbiol, 1994, 13:641-653.
  • 10王辉,陈民钧.北京地区肺炎链球菌的耐药性及其分子流行病学调查[J].中华医学杂志,1999,79(4):253-256. 被引量:97

共引文献235

同被引文献54

引证文献10

二级引证文献31

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部